← Back to Search

Alpha-1 Adrenergic Receptor Antagonist

Tamsulosin for Kidney Stones

N/A
Waitlist Available
Led By Swor Robert, DO
Research Sponsored by Robert Swor
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-7 days
Awards & highlights
All Individual Drugs Already Approved
Approved for 5 Other Conditions

Summary

To determine if emergency department patients with acute ureteral colic pain due to a ureteral stone who are treated with tamsulosin, versus placebo, will experience a shorter time to passage of their stone or resolution of their pain. A secondary study objective will be to determine if there is a relationship between response to tamsulosin and stone size or position in the ureter.

Eligible Conditions
  • Kidney stones
  • Kidney Stones

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-7 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Stone Passage
Secondary study objectives
High Pain Score by Treatment Group

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: TamsulosinActive Control1 Intervention
Intervention - Tamsulosin
Group II: PlaceboPlacebo Group1 Intervention
Placebo

Find a Location

Who is running the clinical trial?

Robert SworLead Sponsor
William Beaumont HospitalsOTHER
151 Previous Clinical Trials
112,483 Total Patients Enrolled
Swor Robert, DOPrincipal InvestigatorWilliam Beaumont Hospitals
~7 spots leftby Nov 2025